Hepatitis B

With collaborators at SLU we have identified a novel molecule series with in vitro activity (novel target/mechanism) and this has been verified by testing using NIAID resources.

Jones T, Tavis JE, Li Q, Riabova O, Monakhova N, Bradley DP, Lane TR, Makarov V, Ekins S. Antiviral Evaluation of Dispirotripiperazines against Hepatitis B Virus. J Med Chem. 2023 Sep 14;66(17):12459-12467